Stay updated on Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial page.

Latest updates to the Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2, indicating a new release of the page metadata. This is a minor update to the documentation/versioning of the page.SummaryDifference0.0%

- Check13 days agoChange DetectedA new Revision: v3.6.2 appears, replacing Revision: v3.6.0, indicating a small update to the site's version tagging.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedNew help and navigation items were added to the page (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) along with a Revision: v3.6.0 tag, and the previous Intervention / Treatment heading and Revision: v3.5.5 tag were removed.SummaryDifference0.5%

- Check35 days agoChange DetectedThe page's revision label was updated to v3.5.5, indicating a new release of the page content without altering the study details.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a small update to the page metadata. This reflects an editorial change to the ClinicalTrials.gov record rather than any substantive study information.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page now displays a new revision label: Revision: v3.5.3, replacing v3.5.2. This signals an update to the page version, with no evident public content changes.SummaryDifference0.0%

Stay in the know with updates to Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial page.